202 related articles for article (PubMed ID: 28353004)
1. The effectiveness of a population-based skin cancer screening program: evidence from Germany.
Kaiser M; Schiller J; Schreckenberger C
Eur J Health Econ; 2018 Apr; 19(3):355-367. PubMed ID: 28353004
[TBL] [Abstract][Full Text] [Related]
2. Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany.
Stang A; Jöckel KH
Cancer; 2016 Feb; 122(3):432-7. PubMed ID: 26480048
[TBL] [Abstract][Full Text] [Related]
3. The many unanswered questions related to the German skin cancer screening programme.
Stang A; Garbe C; Autier P; Jöckel KH
Eur J Cancer; 2016 Sep; 64():83-8. PubMed ID: 27371911
[TBL] [Abstract][Full Text] [Related]
4. Skin cancer rates in North Rhine-Westphalia, Germany before and after the introduction of the nationwide skin cancer screening program (2000-2015).
Stang A; Jöckel KH; Heidinger O
Eur J Epidemiol; 2018 Mar; 33(3):303-312. PubMed ID: 29294207
[TBL] [Abstract][Full Text] [Related]
5. Development of a microsimulation of melanoma mortality for evaluating the effectiveness of population-based skin cancer screening.
Eisemann N; Waldmann A; Garbe C; Katalinic A
Med Decis Making; 2015 Feb; 35(2):243-54. PubMed ID: 25145574
[TBL] [Abstract][Full Text] [Related]
6. Systematic skin cancer screening in Northern Germany.
Breitbart EW; Waldmann A; Nolte S; Capellaro M; Greinert R; Volkmer B; Katalinic A
J Am Acad Dermatol; 2012 Feb; 66(2):201-11. PubMed ID: 22074699
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of skin cancer screening for individuals age 14 to 34 years.
Schmitt J; Seidler A; Heinisch G; Sebastian G
J Dtsch Dermatol Ges; 2011 Aug; 9(8):608-16. PubMed ID: 21501381
[TBL] [Abstract][Full Text] [Related]
8. Skin Cancer Screening in Germany. Documenting Melanoma Incidence and Mortality From 2008 to 2013.
Katalinic A; Eisemann N; Waldmann A
Dtsch Arztebl Int; 2015 Sep; 112(38):629-34. PubMed ID: 26429634
[TBL] [Abstract][Full Text] [Related]
9. Melanoma mortality following skin cancer screening in Germany.
Boniol M; Autier P; Gandini S
BMJ Open; 2015 Sep; 5(9):e008158. PubMed ID: 26373399
[TBL] [Abstract][Full Text] [Related]
10. Melanoma screening: A plan for improving early detection.
Shellenberger R; Nabhan M; Kakaraparthi S
Ann Med; 2016; 48(3):142-8. PubMed ID: 26911192
[TBL] [Abstract][Full Text] [Related]
11. Observed and expected mortality in the German skin cancer screening pilot project SCREEN.
Eisemann N; Waldmann A; Holleczek B; Katalinic A
J Med Screen; 2018 Sep; 25(3):166-168. PubMed ID: 29169295
[TBL] [Abstract][Full Text] [Related]
12. [Skin cancer screening in Germany: review after ten years].
Hübner J; Eisemann N; Brunßen A; Katalinic A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Dec; 61(12):1536-1543. PubMed ID: 30411137
[TBL] [Abstract][Full Text] [Related]
13. Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening.
Waldmann A; Nolte S; Weinstock MA; Breitbart EW; Eisemann N; Geller AC; Greinert R; Volkmer B; Katalinic A
Br J Cancer; 2012 Feb; 106(5):970-4. PubMed ID: 22294187
[TBL] [Abstract][Full Text] [Related]
14. Barriers to Using a Nationwide Skin Cancer Screening Program: Findings from Germany.
Görig T; Schneider S; Schilling L; Diehl K
Oncol Res Treat; 2018; 41(12):774-779. PubMed ID: 30458453
[TBL] [Abstract][Full Text] [Related]
15. [Malignant melanoma of the skin: does screening for cancer influence the incidence and mortality?].
Schubert A
Gesundheitswesen; 2012 Mar; 74(3):154-9. PubMed ID: 21305450
[TBL] [Abstract][Full Text] [Related]
16. Effects of the German skin cancer screening programme on melanoma incidence and indicators of disease severity.
Trautmann F; Meier F; Seidler A; Schmitt J
Br J Dermatol; 2016 Nov; 175(5):912-919. PubMed ID: 27203791
[TBL] [Abstract][Full Text] [Related]
17. Association between risk factors and detection of cutaneous melanoma in the setting of a population-based skin cancer screening.
Hübner J; Waldmann A; Eisemann N; Noftz M; Geller AC; Weinstock MA; Volkmer B; Greinert R; Breitbart EW; Katalinic A
Eur J Cancer Prev; 2018 Nov; 27(6):563-569. PubMed ID: 28692584
[TBL] [Abstract][Full Text] [Related]
18. Frequency of excisions and yields of malignant skin tumors in a population-based screening intervention of 360,288 whole-body examinations.
Waldmann A; Nolte S; Geller AC; Katalinic A; Weinstock MA; Volkmer B; Greinert R; Breitbart EW
Arch Dermatol; 2012 Aug; 148(8):903-10. PubMed ID: 22911184
[TBL] [Abstract][Full Text] [Related]
19. Skin cancer screening campaign in the German speaking Community of Belgium.
Nikkels AF; Nikkels-Tassoudji N; Jerusalem-Noury E; Sandman-Lobusch H; Sproten G; Zeimers G; Schroeder J; Piérard GE
Acta Clin Belg; 2004; 59(4):194-8. PubMed ID: 15597726
[TBL] [Abstract][Full Text] [Related]
20. [Incidence of melanoma and changes in stage-specific incidence after implementation of skin cancer screening in Schleswig-Holstein].
Eisemann N; Waldmann A; Katalinic A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):77-83. PubMed ID: 24357176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
